Carine E Hamo1, Mihai Gheorghiade2, Javed Butler3. 1. Department of Medicine, Division of Cardiology, Stony Brook University, T-16, Room 080, Stony Brook, NY, 11794, USA. 2. Center for Cardiovascular Innovation, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. 3. Department of Medicine, Division of Cardiology, Stony Brook University, T-16, Room 080, Stony Brook, NY, 11794, USA. javed.butler@stonybrookmedicine.edu.
Abstract
PURPOSE OF REVIEW: With the growing prevalence of heart failure, there is a particular need to develop new pharmacologic treatments that can improve outcomes. While there are several approved therapies for heart failure with reduced ejection fraction, there is currently no approved agent for those with preserved ejection fraction. The current review aimed to explore the utility of alternate endpoints to mortality and hospitalization. RECENT FINDINGS: There is increased interest in the use of alternative endpoints such as functional status and quality of life for heart failure drug development to focus on patients feeling better in addition to improving outcomes. This should ideally be measured using objective as well as subjective parameters. While mortality and hospitalization remain important endpoints for clinical trials in heart failure, other more patient-centered outcomes are attractive alternatives yet how to best incorporate these in a trial setting remains to be elucidated.
PURPOSE OF REVIEW: With the growing prevalence of heart failure, there is a particular need to develop new pharmacologic treatments that can improve outcomes. While there are several approved therapies for heart failure with reduced ejection fraction, there is currently no approved agent for those with preserved ejection fraction. The current review aimed to explore the utility of alternate endpoints to mortality and hospitalization. RECENT FINDINGS: There is increased interest in the use of alternative endpoints such as functional status and quality of life for heart failure drug development to focus on patients feeling better in addition to improving outcomes. This should ideally be measured using objective as well as subjective parameters. While mortality and hospitalization remain important endpoints for clinical trials in heart failure, other more patient-centered outcomes are attractive alternatives yet how to best incorporate these in a trial setting remains to be elucidated.
Entities:
Keywords:
Clinical trial; Endpoint; Functional status; Heart failure; Quality of life
Authors: Clyde W Yancy; Mariell Jessup; Biykem Bozkurt; Javed Butler; Donald E Casey; Mark H Drazner; Gregg C Fonarow; Stephen A Geraci; Tamara Horwich; James L Januzzi; Maryl R Johnson; Edward K Kasper; Wayne C Levy; Frederick A Masoudi; Patrick E McBride; John J V McMurray; Judith E Mitchell; Pamela N Peterson; Barbara Riegel; Flora Sam; Lynne W Stevenson; W H Wilson Tang; Emily J Tsai; Bruce L Wilkoff Journal: Circulation Date: 2013-06-05 Impact factor: 29.690
Authors: William T Abraham; Wendy G Stough; Ileana L Piña; Cecilia Linde; Jeffrey S Borer; Gaetano M De Ferrari; Roxana Mehran; Kenneth M Stein; Alphons Vincent; Jay S Yadav; Stefan D Anker; Faiez Zannad Journal: Nat Rev Cardiol Date: 2014-08-12 Impact factor: 32.419
Authors: William T Abraham; Philip B Adamson; Robert C Bourge; Mark F Aaron; Maria Rosa Costanzo; Lynne W Stevenson; Warren Strickland; Suresh Neelagaru; Nirav Raval; Steven Krueger; Stanislav Weiner; David Shavelle; Bradley Jeffries; Jay S Yadav Journal: Lancet Date: 2011-02-19 Impact factor: 79.321
Authors: James P Daubert; Wojciech Zareba; David S Cannom; Scott McNitt; Spencer Z Rosero; Paul Wang; Claudio Schuger; Jonathan S Steinberg; Steven L Higgins; David J Wilber; Helmut Klein; Mark L Andrews; W Jackson Hall; Arthur J Moss Journal: J Am Coll Cardiol Date: 2008-04-08 Impact factor: 24.094
Authors: G H Guyatt; M J Sullivan; P J Thompson; E L Fallen; S O Pugsley; D W Taylor; L B Berman Journal: Can Med Assoc J Date: 1985-04-15 Impact factor: 8.262
Authors: Alan Maisel; Christian Mueller; Kirkwood Adams; Stefan D Anker; Nadia Aspromonte; John G F Cleland; Alain Cohen-Solal; Ulf Dahlstrom; Anthony DeMaria; Salvatore Di Somma; Gerasimos S Filippatos; Gregg C Fonarow; Patrick Jourdain; Michel Komajda; Peter P Liu; Theresa McDonagh; Kenneth McDonald; Alexandre Mebazaa; Markku S Nieminen; W Frank Peacock; Marco Tubaro; Roberto Valle; Marc Vanderhyden; Clyde W Yancy; Faiez Zannad; Eugene Braunwald Journal: Eur J Heart Fail Date: 2008-08-29 Impact factor: 15.534
Authors: Stefan D Anker; Stefan Schroeder; Dan Atar; Jeroen J Bax; Claudio Ceconi; Martin R Cowie; Adam Crisp; Fabienne Dominjon; Ian Ford; Hossein-Ardeschir Ghofrani; Savion Gropper; Gerhard Hindricks; Mark A Hlatky; Richard Holcomb; Narimon Honarpour; J Wouter Jukema; Albert M Kim; Michael Kunz; Martin Lefkowitz; Chantal Le Floch; Ulf Landmesser; Theresa A McDonagh; John J McMurray; Bela Merkely; Milton Packer; Krishna Prasad; James Revkin; Giuseppe M C Rosano; Ransi Somaratne; Wendy Gattis Stough; Adriaan A Voors; Frank Ruschitzka Journal: Eur J Heart Fail Date: 2016-04-12 Impact factor: 15.534
Authors: Faiez Zannad; Angeles Alonso Garcia; Stefan D Anker; Paul W Armstrong; Gonzalo Calvo; John G F Cleland; Jay N Cohn; Kenneth Dickstein; Michael J Domanski; Inger Ekman; Gerasimos S Filippatos; Mihai Gheorghiade; Adrian F Hernandez; Tiny Jaarsma; Joerg Koglin; Marvin Konstam; Stuart Kupfer; Aldo P Maggioni; Alexandre Mebazaa; Marco Metra; Christina Nowack; Burkert Pieske; Ileana L Piña; Stuart J Pocock; Piotr Ponikowski; Giuseppe Rosano; Luis M Ruilope; Frank Ruschitzka; Thomas Severin; Scott Solomon; Kenneth Stein; Norman L Stockbridge; Wendy Gattis Stough; Karl Swedberg; Luigi Tavazzi; Adriaan A Voors; Scott M Wasserman; Holger Woehrle; Andrew Zalewski; John J V McMurray Journal: Eur J Heart Fail Date: 2013-06-19 Impact factor: 15.534
Authors: Ana Elisa M Martinelli; Raul C Maranhão; Priscila O Carvalho; Fatima R Freitas; Bruna M O Silva; Milena N C Curiati; Roberto Kalil Filho; Antonio Carlos Pereira-Barretto Journal: Lipids Health Dis Date: 2018-10-20 Impact factor: 3.876
Authors: Muhammad Shahzeb Khan; Tariq Jamal Siddiqi; Javed Butler; Tim Friede; Wayne C Levy; Klaus K Witte; Janusz Lipiecki; Horst Sievert; Andrew J Stewart Coats Journal: ESC Heart Fail Date: 2021-02-22